Skip to main content
Log in

Correction of cardiotoxic effects of cardiac antiarrhythmics with befol, suphan, and their combinations

  • Pharmacology and Toxicology
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

Antidepressant befol, non-glycoside cardiotonic suphan, and their combinations were shown to have different ability to decrease cardiotoxic (arrhythmogenic) effect of novocainamide, lidocaine, bonnecor, obsidan, cordarone, verapamil, and rhythmidazol.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. E. M. Gankina, M. F. Mineeva, D. Yu. Rusakovet al., In:A New Original Antidepressant Befol [in Russian], 69–87, Moscow (1990).

  2. V. V. Gatsura,Pharmacological Correction of Energy Exchange in the Ischemic Myocardium [in Russian], Moscow (1993).

  3. A. I. Grinevich, I. S. Checkman, P. A. Galenko-Yaroshevskiiet al., Dokl. AN Ukrainy, No. 5, 169–173 (1994).

    Google Scholar 

  4. S. G. Kanorskii,Combinatory Pharmacotherapy with Antia-arrhythmics and Psychotropic Drugs With the Help of Electrophysiological Tests [in Russian], Abstr. of Ph. D. Thesis, Krasnodar (1993).

  5. M. S. Kushakovskii,Cardiac Arrhythmias [in Russian], St. Petersburg (1992).

  6. F. Z. Meerson, M. G. Pshennikova,Adaptation to Stress and Physical Loads, Moscow (1988).

  7. V. B. Prozorovskii,Farmakol. Toksilkol., No. 2, 33–37 (1984).

    Google Scholar 

  8. V. B. Prozorovskii and M. P. Prozorovskaya,Farmakol. Toksikol.,43, No. 6, 733–735 (1980).

    PubMed  CAS  Google Scholar 

  9. V. V. Skibitskii,Pharmacological Activation of Stress Limiting Systems in Arrhythmia Therapy, Abstr. of M. D. Thesis, Moscow (1995).

  10. A. I. Khankoeva,A Study of Ways of Diminishing Cardiotoxic effect of Antiarrhythmics in Myocardial Ischemia Conditions, Abstr. of Ph. D. Thesis, Rostov-on-Don (1995).

  11. L. E. Kholodov, V. P. Yakovlev,Clinical Pharmacokinetics [in Russian], Moscow (1985).

  12. Yu. K. Chipizubov,Lipid Peroxidation and Antioxidant Blood Activity in Patients with Arrhythmias In the Course of Pharmacotherapy [in Russian], Abstr. of Ph. D. Thesis, Krasnodar (1993).

  13. S. Loewe,Ergebn. Physiol.,27, 47 (1928).

    Google Scholar 

  14. S. Loewe,Pharmacol. Rev.,9, 237–242 (1957).

    PubMed  CAS  Google Scholar 

  15. B. Lown, R. Dasilova, P. Reich, and B. Murawski,Am. J. Psychiatry,137, No. 11, 1325–1335 (1980).

    PubMed  CAS  Google Scholar 

  16. E. M. Vaughan Williams,Clinical Pharmacol.,24, No. 1, 129–147 (1984).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 125, No. 6, pp. 641–646, June, 1998

Rights and permissions

Reprints and permissions

About this article

Cite this article

Galenko-Yaroshevskii, P.A., Khankoeva, A.I., Uvarov, A.V. et al. Correction of cardiotoxic effects of cardiac antiarrhythmics with befol, suphan, and their combinations. Bull Exp Biol Med 125, 567–572 (1998). https://doi.org/10.1007/BF02445242

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02445242

Key Words

Navigation